Mineralys insider plans $10.6K stock sale

Mineralys Therapeutics, Inc. insider David Rodman filed to sell common stock of Mineralys Therapeutics, Inc. (MLYS).

Rhea-AI Filing Summary

Mineralys Therapeutics, Inc. insider David Rodman filed to sell common stock of Mineralys Therapeutics, Inc. (MLYS). The planned sale involves 417 shares of common stock through Merrill Lynch on 08/17/2026, related to the exercise of employee stock options using a broker-assisted cashless exercise. The disclosure also lists multiple prior sales of Mineralys common stock by David Rodman over the past three months, each with specified share amounts and dollar values.

Key Figures

Proposed shares to be sold: 417 shares Associated value with proposed 417-share entry: $10,616.82 Prior sale 05/18/2026: 417 shares for $11,488.35 +4 more

7 metrics

Proposed shares to be sold 417 shares Common stock sale tied to employee stock option exercise on 08/17/2026

Associated value with proposed 417-share entry $10,616.82 Common stock entry with Merrill Lynch for 417 shares

Prior sale 05/18/2026 417 shares for $11,488.35 Common stock sale by David Rodman during past 3 months

Prior sale 06/10/2026 2,170 shares for $54,250.00 Common stock sale by David Rodman

Prior sale 06/15/2026 9,890 shares for $235,487.24 Common stock sale by David Rodman

Prior sale 07/13/2026 14,058 shares for $387,716.51 Common stock sale by David Rodman

Prior sale 08/13/2026 14,056 shares for $372,187.00 Common stock sale by David Rodman

Key Terms

Form 144, cashless exercise, exercise of employee stock options, broker assisted

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cashless exercise financial

"Broker assisted with cashless exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

exercise of employee stock options financial

"Exercise of employee stock options"

broker assisted financial

"Broker assisted with cashless exercise"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock is involved in David Rodman’s Form 144 for Mineralys Therapeutics (MLYS)?

The Form 144 covers common stock of Mineralys Therapeutics, Inc. (MLYS). The notice identifies proposed and recent sales of this common stock by David Rodman, including an upcoming transaction tied to an employee stock option exercise.

How many Mineralys Therapeutics (MLYS) shares are proposed to be sold on 08/17/2026?

The proposed sale on 08/17/2026 involves 417 shares of Mineralys Therapeutics common stock. This transaction is connected to the exercise of employee stock options and is described as a broker-assisted cashless exercise through Merrill Lynch.

What is the value associated with the 417 Mineralys (MLYS) shares listed with Merrill Lynch?

The 417 shares of Mineralys common stock listed with Merrill Lynch are associated with a value of $10,616.82. This figure appears in the securities information section along with the 417-share amount and the planned sale date of 08/17/2026.

What prior Mineralys Therapeutics (MLYS) stock sales by David Rodman are disclosed?

The disclosure lists several prior sales of Mineralys common stock by David Rodman, including 417 shares for $11,488.35 on 05/18/2026 and 2,170 shares for $54,250.00 on 06/10/2026, along with multiple larger transactions in June, July, and August 2026.

Are the recent Mineralys (MLYS) stock sales by David Rodman sizable individual transactions?

Some disclosed transactions are sizable, such as 9,890 shares for $235,487.24 on 06/15/2026 and 14,058 shares for $387,716.51 on 07/13/2026. Each entry specifies the number of common shares sold and the total dollar amount received.

How is the 08/17/2026 Mineralys (MLYS) transaction described in relation to stock options?

The 08/17/2026 transaction is described as an exercise of employee stock options for Mineralys common stock. It is further characterized as a broker assisted with cashless exercise, meaning the broker facilitates the option exercise and share sale in one combined process.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:40 PM Accepted by SEC EDGAR 08/17/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001672659
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mineralys Therapeutics, Inc.
SEC File Number	001-41614
Address of Issuer	150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PENNSYLVANIA 19087
Phone	(888) 378-6240
Name of Person for Whose Account the Securities are To Be Sold	Rodman David Malcom
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	417	10616.82	82498101	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/17/2026	Exercise of employee stock options	Mineralys Therapeutics, Inc.			417	08/17/2026	Broker assisted with cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	05/18/2026	417	11488.35
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/10/2026	2170	54250.00
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/12/2026	6349	151901.37
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/15/2026	9890	235487.24
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	06/17/2026	4584	114600.00
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/09/2026	2171	65781.30
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/13/2026	14058	387716.51
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/15/2026	6349	168954.55
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	07/17/2026	416	11016.30
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	08/10/2026	2170	58785.30
David Rodman 150 N. RADNOR CHESTER RD SUITE F200 RADNOR PA 19087	Common Stock	08/13/2026	14056	372187.00

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Rodman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)